Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:27 pm Purchase | 2025-12-31 | 13G | SAVARA INC SVRA | TCG Crossover GP I, LLC | 12,362,205 6.100% | 2,362,205 (+23.62%) | Filing History |
| 2025-11-25 4:29 pm Purchase | 2025-11-19 | 13G | ENTRADA THERAPEUTICS INC TRDA | TCG Crossover GP I, LLC | 1,917,344 5.000% | 1,917,344 (New Position) | Filing History |
| 2025-11-14 4:27 pm Sale | 2025-09-30 | 13G | UPSTREAM BIO INC UPB | TCG Crossover GP I, LLC | 2,117,103 3.900% | -684,660 (-24.44%) | Filing History |
| 2025-11-14 4:25 pm Purchase | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I, LLC | 6,798,162 4.800% | 1,167,120 (+20.73%) | Filing History |
| 2025-11-14 4:22 pm Purchase | 2025-09-30 | 13G | ABIVAX SA SPONSORED ADS ABVX | TCG Crossover GP I, LLC | 7,111,596 9.100% | 1,055,000 (+17.42%) | Filing History |
| 2025-08-14 5:09 pm Sale | 2025-06-30 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | TCG Crossover GP I, LLC | 3,858,000 3.900% | -2,579,497 (-40.07%) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-04-28 | 13G | JADE BIOSCIENCES, INC. JBIO | TCG Crossover GP I, LLC | 64,023 0.200% | 1,129 (+1.80%) | Filing History |
| 2025-05-15 4:32 pm Purchase | 2025-03-31 | 13G | CG ONCOLOGY INC CGON | TCG Crossover GP I, LLC | 3,670,206 4.800% | 100,000 (+2.80%) | Filing History |
| 2025-03-06 6:02 pm Purchase | 2025-02-27 | 13G | TYRA BIOSCIENCES INC TYRA | TCG Crossover GP I, LLC | 2,898,103 5.700% | 2,898,103 (New Position) | Filing History |
| 2025-02-14 4:44 pm Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I, LLC | 0 0.000% | -1,555,118 (Position Closed) | Filing History |
| 2025-02-14 4:23 pm Purchase | 2024-12-31 | 13G | UPSTREAM BIO INC UPB | TCG Crossover GP I, LLC | 2,801,763 5.200% | 2,801,763 (New Position) | Filing History |
| 2024-11-13 4:25 pm Sale | 2024-09-30 | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I, LLC | 1,555,118 5.200% | -1,123,091 (-41.93%) | Filing History |
| 2024-04-19 7:09 pm Purchase | 2024-04-11 | 13G | ABIVAX SA SPONSORED ADS ABVX | TCG Crossover GP I, LLC | 6,056,596 9.600% | 6,056,596 (New Position) | Filing History |
| 2024-04-01 4:14 pm Sale | 2024-03-28 | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I, LLC | 1,345,826 3.200% | -1,355,014 (-50.17%) | Filing History |
| 2024-02-20 4:49 pm Sale | 2024-02-07 | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I, LLC | 2,700,840 6.520% | -707,241 (-20.75%) | Filing History |
| 2024-02-13 4:27 pm Sale | 2023-12-31 | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover GP I, LLC | 0 0.000% | -5,905,400 (Position Closed) | Filing History |
| 2024-02-09 4:31 pm Purchase | 2024-01-29 | 13G | CG ONCOLOGY INC CGON | TCG Crossover GP I, LLC | 3,570,206 5.400% | 3,570,206 (New Position) | Filing History |
| 2024-02-09 4:29 pm Purchase | 2023-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I, LLC | 2,678,209 9.000% | 1,388,889 (+107.72%) | Filing History |
| 2024-02-09 4:28 pm Purchase | 2023-06-16 | 13G | AEROVATE THERAPEUTICS INC AVTE | TCG Crossover GP I, LLC | 62,894 8.000% | 62,894 (New Position) | Filing History |
| 2024-02-09 4:24 pm Sale | 2023-12-31 | 13G | TAYSHA GENE THERAPIES INC TSHA | TCG Crossover GP I, LLC | 2,912,861 1.600% | -8,198,250 (-73.78%) | Filing History |